Charles Cherington - 09 Jun 2025 Form 4 Insider Report for Ernexa Therapeutics Inc. (ERNA)

Role
10%+ Owner
Signature
/s/ Charles Cherington
Issuer symbol
ERNA
Transactions as of
09 Jun 2025
Net transactions value
+$2,221,826
Form type
4
Filing time
11 Jun 2025, 20:34:12 UTC
Previous filing
04 Apr 2025
Next filing
17 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cherington Charles 10%+ Owner 200 BERKLEY STREET, 26TH FLOOR, BOSTON /s/ Charles Cherington 11 Jun 2025 0001448698

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERNA Common Stock Purchase $2,221,826 +21,241,163 +104% $0.1046 41,659,743 09 Jun 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 9, 2025, pursuant to a private placement offering by the Issuer and following the receipt of stockholder approval, the reporting person acquired 21,241,163 shares of the Issuer's Common Stock.
F2 On June 2, 2025, the Issuer paid a dividend to all holders of record of its Series A Preferred Stock on such date of $0.05 per share of Series A Preferred Stock. Pursuant to the terms of the Series A Preferred Stock, the Issuer elected to pay the dividend in an equivalent amount of Common Stock. As a result, the Reporting Person received 16,978 shares of the Issuer's Common Stock.